Similar Articles

Long-term cladribine experience in relapsing-remitting multiple sclerosis

Ömer Faruk Turan, Furkan Sarıdaş, Emine Rabia Koç

DOI: 10.55697/tnd.2025.293

Issue: 2025, Volume 31 - Issue 3
2160 1989

Association between urinary symptoms, quality of life, and pelvic floor function in females diagnosed with multiple sclerosis

Seda Kılıç, Ayşe Neriman Yılmaz, Murat Terzi

DOI: 10.55697/tnd.2025.323

Issue: 2025, Volume 31 - Issue 4
1450 1374

Audiovestibular findings according to the subtypes of multiple sclerosis

Fatmanur Uysal, Selim S. Erbek, Alper Köycü, Osman Halit Çam, Meliha Güleryüz

DOI: 10.55697/tnd.2025.442

Issue: 2025, Volume 31 - Issue 4
1377 1614

Development of restless legs syndrome severity prediction models for people with multiple sclerosis using machine learning

Ergi Kaya, Murat Emeç, Asiye Tuba Özdoğar, Ela Simay Zengin, Hilal Karakaş, Seda Daştan, Cavid Baba, Mehmet Hilal Özcanhan, Serkan Özakbaş

DOI: 10.55697/tnd.2025.511

Issue: 2025, Volume 31 - Issue 4
1630 1544

Nationwide prescription big data: An evaluation of injectable, oral, and monoclonal antibody disease-modifying therapies in multiple sclerosis

Esra Taşkıran, Bilgin Öztürk, Naim Ata, Şuayip Birinci

DOI: 10.55697/tnd.2026.622

Issue: 2026, Volume 32 - Issue 1
1331 876

Rehabilitation of swallowing disorders in patients with schizophrenia: A pilot study on efficacy and feasibility

Neslihan Altuntaş Yılmaz, Adem Aydın, Muzaffer Şeker, Ayşe Merve Tat, Gökmen Yapali

DOI: 10.55697/tnd.2026.542

Issue: 2026, Volume 32 - Issue 2
1491 648

Recorded diagnosis-based incidence and point prevalence of multiple sclerosis in Azerbaijan between 2013 and 2022: Estimates from a national referral center registry

Rahim Aliyev, Ayten Mammadbayli, Rana Shiraliyeva

DOI: 10.55697/tnd.2026.749

Issue: 2026, Volume 32 - Issue 3
298 195